Role of Home-based Transcutaneous Electrical Acustimulation for Treatment of Pain in Patients With Chronic Pancreatitis

Inclusion Criteria: Diagnosis of chronic pancreatitis (CP), based on a score greater or equal to 4 using a previously validated Mayo scoring system that uses morphologic and functional criteria, or endosonographic features suggestive or consistent with CP based on Rosemont criteria. Abdominal pain present at least once within the last month Willing and able to provide written informed consent Exclusion Criteria: Pregnancy or breastfeeding mother Imprisoned individuals Non-English speaking patients Scheduled for or with a history of pancreatic surgery (e.g. Total Pancreatectomy with Islet Auto Transplantation (TPIAT), Puestow, Frey, Whipple, other) Currently undergoing or about to start endoscopic therapy with Endoscopic retrograde cholangiopancreatography (ERCP) or Endoscopic ultrasound (EUS) Recent history of acute pancreatitis as defined by the Revised Atlanta Classification within a month prior to enrollment Radiologic and clinical findings consistent with symptomatic pseudocyst, wall-off necrosis, infected pancreatic necrosis, or biliary obstruction within the last 6 months Self-reported daily use of opioids for > 12 months for weak opioids (codeine, tramadol and hydrocodone) or > 6 months for strong opioids (other opioids) in the last two years. -Self-reported ongoing illicit drug use or abuse- Suspected or diagnosed pancreatic cancer Receiving chemotherapy for cancer Known allergy to adhesive electrocardiogram (ECG) electrodes Patients with bilateral below the knee amputation Patients with lower extremity paralysis Patient is participating in another clinical trial Patients with an implantable electrical stimulation device.